Japanese Pharmaceuticals & Biotech Upcoming Dividends

Ono Pharmaceutical

Market Cap: JP¥735.4b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Kaken Pharmaceutical

Market Cap: JP¥145.6b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

Takeda Pharmaceutical

Market Cap: JP¥6.7t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Linical

Market Cap: JP¥7.1b

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

Santen Pharmaceutical

Market Cap: JP¥547.2b

Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.

Shionogi

Market Cap: JP¥2.0t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Fuji Pharma

Market Cap: JP¥32.2b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Zeria Pharmaceutical

Market Cap: JP¥95.9b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally.

Sawai Group Holdings

Market Cap: JP¥206.3b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Kissei Pharmaceutical

Market Cap: JP¥177.8b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Astellas Pharma

Market Cap: JP¥2.6t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Nippon Shinyaku

Market Cap: JP¥239.9b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Tsumura

Market Cap: JP¥256.8b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Daito PharmaceuticalLtd

Market Cap: JP¥29.5b

Manufactures and sells pharmaceutical products worldwide.

Astena Holdings

Market Cap: JP¥19.0b

Manufactures and sells medicine-related products in Japan.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥66.2b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Mochida Pharmaceutical

Market Cap: JP¥106.1b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

Pharma Foods International

Market Cap: JP¥28.1b

Engages in the development and sale of functional food ingredients in Japan.

Otsuka Holdings

Market Cap: JP¥3.9t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Fuso Pharmaceutical IndustriesLtd

Market Cap: JP¥18.3b

Manufactures and sells pharmaceuticals and medical equipment in Japan.

Chugai Pharmaceutical

Market Cap: JP¥12.5t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥7.2t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

JCR Pharmaceuticals

Market Cap: JP¥65.9b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Towa Pharmaceutical

Market Cap: JP¥150.4b

Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.

Seikagaku

Market Cap: JP¥35.3b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

KYORIN Pharmaceutical

Market Cap: JP¥86.5b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.